<DOC>
	<DOCNO>NCT00594607</DOCNO>
	<brief_summary>The purpose study investigate whether dialysis filter AN69ST ( Nephral 400 ST Dialysis Membrane ) induce less clot hemodialysis conventional polysulphone filter . Our hypothesis two filter induce degree clotting .</brief_summary>
	<brief_title>Effect Nephral 400 ST Dialysis Membrane Coagulation Hemodialysis</brief_title>
	<detailed_description>Six consecutive hemodialysis ( HD ) session evaluate per patient , altogether 10 - 12 stable HD patient ( least 48 HD session altogether ) . During six session , AN69ST Fx8 use alternate day . Dalteparin give intravenously single bolus dose start HD ( 50 % conventional dose ) . Clinical clotting evaluate visually hour HD blood drain venous air trap : 1=no clot , 2=a fibrinous ring , 3=a clot &lt; 1 cm , 4=a clot &gt; 1 cm 5=coagulated system ( stop HD ) . Blood specimen take start hour HD . Markers coagulation ( prothrombin 1+2 ) platelet ( beta-thromboglobulin ) evaluate well anti FXa-activity . The two filter go compare statistically respect degree clinical clotting intravascular coagulation platelet activation .</detailed_description>
	<criteria>patient age 18 year chronic HD least 1 month dialysis time least 4 hour 3 time per week blood flow least 200 ml/min Fragmin dose unchanged last week study start Fragmin give intravenously one single dose HD start Haemoglobin &gt; = 11.0 g/dL stable +/ 20 % last week study start erythropoietin iron dose unchanged last week study start write orally informed consent give patient treatment acetylsalicylic acid ( ASA ) use Warfarin another oral anticoagulant clinical sign infection disseminate malignant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>clot</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>bleeding risk</keyword>
</DOC>